TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial

Doxycycline for Stabilization of Abdominal Aortic Aneurysms

(2016) C. Arnoud Meijer et al.   ANNALS OF INTERNAL MEDICINE

Fenofibrate Increases High-Density Lipoprotein and Sphingosine 1 Phosphate Concentrations Limiting Abdominal Aortic Aneurysm Progression in a Mouse Model

(2012) Smriti M. Krishna et al.   AMERICAN JOURNAL OF PATHOLOGY

Efficacy and Mechanism of Angiotensin II Receptor Blocker Treatment in Experimental Abdominal Aortic Aneurysms

(2012) Yasunori Iida et al.   PLoS One

Current status of medical management for abdominal aortic aneurysm

(2011) Jonathan Golledge et al.   ATHEROSCLEROSIS

Systematic review and meta-analysis of growth rates of small abdominal aortic aneurysms

(2011) J. T. Powell et al.   BRITISH JOURNAL OF SURGERY

2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline)

(2011) Thom W. Rooke et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism

(2011) J. P. Habashi et al.   SCIENCE

Association of statin prescription with small abdominal aortic aneurysm progression

(2010) Craig D. Ferguson et al.   AMERICAN HEART JOURNAL

Diagnosis and Monitoring of Abdominal Aortic Aneurysm: Current Status and Future Prospects

(2010) Joseph V. Moxon et al.   CURRENT PROBLEMS IN CARDIOLOGY

Evaluation of the diagnostic and prognostic value of plasma D-dimer for abdominal aortic aneurysm

(2010) J. Golledge et al.   EUROPEAN HEART JOURNAL

Comparison of volume and diameter measurement in assessing small abdominal aortic aneurysm expansion examined using computed tomographic angiography

(2010) Adam Parr et al.   EUROPEAN JOURNAL OF RADIOLOGY

Impact of RGS2 deficiency on the therapeutic effect of telmisartan in angiotensin II-induced aortic aneurysm

(2010) Sachiko Matsumoto et al.   HYPERTENSION RESEARCH

Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms

(2010) Michael J. Sweeting et al.   JOURNAL OF VASCULAR SURGERY

An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance

(2010) Andrew Thompson et al.   JOURNAL OF VASCULAR SURGERY

Endovascular versus Open Repair of Abdominal Aortic Aneurysm

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm

(2009) Jonathan Golledge et al.   ATHEROSCLEROSIS

Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm

(2009) Catherine Rush et al.   BMC GENOMICS

Rosiglitazone Reduces the Development and Rupture of Experimental Aortic Aneurysms

(2009) Alun Jones et al.   CIRCULATION

Association of PPARγ allelic variation, osteoprotegerin and abdominal aortic aneurysm

(2009) Corey S. Moran et al.   CLINICAL ENDOCRINOLOGY

Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions

(2008) J. Golledge et al.   EUROPEAN HEART JOURNAL

Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation

(2008) Elena Kaschina et al.   JOURNAL OF HYPERTENSION

Interaction between Angiotensin II, Osteoprotegerin, and Peroxisome Proliferator-Activated Receptor-γ in Abdominal Aortic Aneurysm

(2008) Corey S. Moran et al.   JOURNAL OF VASCULAR RESEARCH

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Angiotensin II Blockade in Marfan's Syndrome

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan, Ramipril, or Both in Patients at High Risk of Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE